Cardene Iv Injection, Solution
Product Images NDC 43066-021

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cardene Iv (NDC 43066-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cardene Structural Formula (Image 01)

Chemical structure diagram of nicardipine hydrochloride, showing the molecular components and arrangement of the active ingredient in Cardene IV injection solution.*

FDA Label Image

Novaplus Symbol (Image 02)

Packaging label for Cardene I.V. Injection, containing nicardipine hydrochloride at 0.1 mg/mL strength, presented as 20 mg in 200 mL solution. The label indicates it is a sterile, nonpyrogenic intravenous injection in an iso-osmotic single-dose container. Manufactured and marketed by Baxter Healthcare Corporation, the label includes dosage, storage instructions, and cautionary notes.*

FDA Label Image

Representative Cardene Vizient 20 mg Container Label 43066-021-10 1 Of 2 (Image 03)

A small label featuring a barcode and the text '* BAR CODE POSITION ONLY'. The label is plain with a black border and the barcode number 343066021108 displayed vertically on the right side.*

FDA Label Image

Representative Cardene Vizient 20 mg Container Label 43066-021-10 2 Of 2 (Image 04)

Label for Cardene I.V. Injection, a solution containing nicardipine hydrochloride 0.1 mg/mL in 0.86% sodium chloride. The package contains 20 mg in 200 mL. It is marked Rx only, sterile, nonpyrogenic, and is manufactured and marketed by Baxter Healthcare Corporation. The label includes dosage form, storage instructions, and manufacturer information.*

FDA Label Image

Representative Cardene Vizient 20 mg Carton Label 43066-021-10 1 Of 2 (Image 05)

Cardene IV 0.2 mg/mL nicardipine hydrochloride injection in 200 mL solution. Label indicates 40 mg in 200 mL intravenous use solution with 0.83% sodium chloride. Manufactured and marketed by Baxter Healthcare Corporation. Packaging includes dosage, storage instructions, and caution information.*

FDA Label Image

Representative Cardene Vizient 20 mg Carton Label 43066-021-10 2 Of 2 (Image 06)

Packaging label for Cardene IV (nicardipine hydrochloride) injection, solution. The label includes a barcode with the code 3430606024109 and the text '*BAR CODE POSITION ONLY.' No other product details are visible.*

FDA Label Image

Representative Cardene Vizient 20 mg Shipper Label 43066-021-10 1 Of 2 (Image 07)

Cardene IV 0.2 mg/mL (40 mg in 200 mL) injection solution carton label. Contains nicardipine hydrochloride in 0.83% sodium chloride for intravenous use. Label highlights double concentration warning to check infusion rate. Manufactured by Baxter Healthcare Corporation under the Novaplus brand, the sterile, nonpyrogenic solution is provided in a single-dose container. Storage instructions and product trademarks are included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.